Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mohammed A Aljama

Showing results (1-10 of 21) with videos related to

Pageof 3
Sort By:
Panminerva Medica|October 11, 2018
Therapy for relapsed multiple myelomaMohammed A Aljama, M Hasib Sidiqi, David Dingli
Cancer Medicine|March 3, 2015
Association of dose escalation of octreotide long-acting release on clinical symptoms and tumor markers and response among patients with neuroendocrine tumorsKhalid Al-Efraij, Mohammed A Aljama, Hagen Fritz Kennecke
Leukemia & Lymphoma|January 21, 2025
Are we maintaining minimal residual disease in myeloma?Mohammed A Aljama, Hasib M Sidiqi, Morie A Gertz
Haematologica|September 22, 2018
T-cell large granular lymphocytic leukemia and plasma cell disordersM Hasib Sidiqi, Mohammed A Aljama, David S Viswanatha, et al.
Cancers|January 11, 2022
Checkpoint Inhibitors in Multiple Myeloma: Intriguing Potential and Unfulfilled PromisesOmar Alkharabsheh, Zachary Trisel, Sunil Badami, et al.
Acta Haematologica|July 17, 2019
The Human Microbiota in Multiple Myeloma and Proteasome InhibitorsOmar Alkharabsheh, M Hasib Sidiqi, Mohammed A Aljama, et al.
Clinical and Experimental Gastroenterology|June 23, 2011
Thromboembolism in inflammatory bowel diseases: a report from Saudi ArabiaHussain Issa, Sami Al-Momen, Bahaa Bseiso, et al.
Cancer|April 4, 2022
Impact of autologous transplantation on survival in patients with newly diagnosed multiple myeloma who have high-risk cytogenetics: A meta-analysis of randomized controlled trialsRajshekhar Chakraborty, Rabbia Siddiqi, Gloria Willson, et al.
Leukemia Research|June 7, 2023
Incidence of second primary malignancies in patients with multiple myeloma receiving anti-CD38 monoclonal antibodies: A systematic review and meta-analysisAgrima Mian, Syed Arsalan Ahmed Naqvi, Ahsan Ayaz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 21, 2018
Stem Cell Transplantation for Light Chain Amyloidosis: Decreased Early Mortality Over TimeM Hasib Sidiqi, Mohammed A Aljama, Francis K Buadi, et al.
Pageof 3

Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
Panminerva Medica|October 11, 2018
Therapy for relapsed multiple myelomaMohammed A Aljama, M Hasib Sidiqi, David Dingli
Cancer Medicine|March 3, 2015
Association of dose escalation of octreotide long-acting release on clinical symptoms and tumor markers and response among patients with neuroendocrine tumorsKhalid Al-Efraij, Mohammed A Aljama, Hagen Fritz Kennecke
Leukemia & Lymphoma|January 21, 2025
Are we maintaining minimal residual disease in myeloma?Mohammed A Aljama, Hasib M Sidiqi, Morie A Gertz
Haematologica|September 22, 2018
T-cell large granular lymphocytic leukemia and plasma cell disordersM Hasib Sidiqi, Mohammed A Aljama, David S Viswanatha, et al.
Cancers|January 11, 2022
Checkpoint Inhibitors in Multiple Myeloma: Intriguing Potential and Unfulfilled PromisesOmar Alkharabsheh, Zachary Trisel, Sunil Badami, et al.
Acta Haematologica|July 17, 2019
The Human Microbiota in Multiple Myeloma and Proteasome InhibitorsOmar Alkharabsheh, M Hasib Sidiqi, Mohammed A Aljama, et al.
Clinical and Experimental Gastroenterology|June 23, 2011
Thromboembolism in inflammatory bowel diseases: a report from Saudi ArabiaHussain Issa, Sami Al-Momen, Bahaa Bseiso, et al.
Cancer|April 4, 2022
Impact of autologous transplantation on survival in patients with newly diagnosed multiple myeloma who have high-risk cytogenetics: A meta-analysis of randomized controlled trialsRajshekhar Chakraborty, Rabbia Siddiqi, Gloria Willson, et al.
Leukemia Research|June 7, 2023
Incidence of second primary malignancies in patients with multiple myeloma receiving anti-CD38 monoclonal antibodies: A systematic review and meta-analysisAgrima Mian, Syed Arsalan Ahmed Naqvi, Ahsan Ayaz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 21, 2018
Stem Cell Transplantation for Light Chain Amyloidosis: Decreased Early Mortality Over TimeM Hasib Sidiqi, Mohammed A Aljama, Francis K Buadi, et al.
Pageof 3